China has established a genome engineering and therapy research center in Shenzhen, south China's Guangdong Province, China Science Daily reported Monday.
The Center for Genome Engineering and Therapy is engaged in deepening research on genome editing, gene therapy and cell therapy, as well as bringing China's synthetic biology in line with international practices.
The center will research cutting-edge gene technologies to uncover therapies to fight against major diseases, and develop precision medicine based on machine learning and artificial intelligence, according to the Shenzhen Institute of Advanced Technology of the Chinese Academy of Sciences.
Harvard geneticist George Church was invited to the center. (Xinhua)
Researchers from the Qingdao Institute of Bioenergy and Bioprocess Technology have combined the single-cell sample preparation and sequencing methods into a single, streamlined approach called the Addressable Dynamic Droplet Array (aDDA).
A recent study led by Dr. TAN Zheng from the Institute of Zoology revealed that single nucleotide variations (SNVs) in human genomes interact with DNA motifs that can form four-stranded secondary structures called G-quadruplexes (G4s).
86-10-68597521 (day)
86-10-68597289 (night)
86-10-68511095 (day)
86-10-68512458 (night)
cas_en@cas.cn
52 Sanlihe Rd., Xicheng District,
Beijing, China (100864)
Copyright © 2002 - Chinese Academy of Sciences
